Manchester Financial Inc Exelixis, Inc. Transaction History

Manchester Financial Inc

  • $380 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021
SELL
$17.95 - $25.56 $29,617 - $42,174
-1,650 Closed
0 $0
Q4 2019

Jan 17, 2020
BUY
$15.15 - $18.89 $24,997 - $31,168
1,650 New
1,650 $29,000
Q3 2019

Oct 09, 2019
SELL
$17.68 - $22.65 $17,680 - $22,650
-1,000 Closed
0 $0
Q2 2019

Jul 23, 2019
BUY
$18.93 - $24.75 $18,930 - $24,750
1,000 New
1,000 $21,000

Others Institutions Holding EXEL

# of Institutions
460
Shares Held
240M
Call Options Held
2.04M
Put Options Held
1.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $8.53B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Manchester Financial Inc Portfolio

Follow Manchester Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email